State Street Corp Sio Gene Therapies Inc. Transaction History

State Street Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.4 - $0.46 $69,448 - $79,865	-173,621 Closed	0 $0
Q2 2022 Aug 15, 2022	BUY	$0.25 - $0.73 $1,625 - $4,745	6,500 Added 3.89%	173,621 $63,000
Q1 2022 May 16, 2022	BUY	$0.55 - $1.47 $5,456 - $14,583	9,921 Added 6.31%	167,121 $112,000
Q4 2021 Feb 14, 2022	BUY	$1.29 - $2.36 $60,888 - $111,392	47,200 Added 42.91%	157,200 $203,000
Q3 2021 Nov 15, 2021	BUY	$1.81 - $2.7 $55,929 - $83,430	30,900 Added 39.06%	110,000 $239,000
Q2 2021 Aug 16, 2021	BUY	$2.07 - $2.89 $163,737 - $228,599	79,100 New	79,100 $216,000

147K

Ticker SIOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,975,200
Description
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical S...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.